We are seeking a motivated Scientific Officer to join the Sarcoma Molecular Pathology Group under the leadership of Professor Janet Shipley. You will provide key technical support to ongoing research programmes focused on the molecular characterisation of sarcomas, contributing to projects that directly support the development of improved diagnostics and therapeutic strategies.
Your work will involvescreening, testing, and optimising antibodiesthat detect aberrant proteins in sarcomas. You will use these and commercially available antibodies instate‑of‑the‑art multiplexed immunofluorescent analysesof patient-derived sarcoma tissues and experimental models. The role will also includetissue organisation,tissue culture, andgeneral laboratory managementtasks essential to the smooth running of the research group.
This is an excellent opportunity to be part of a dynamic, collaborative team and contribute to impactful translational cancer research.
About you
The successful candidate must have:
1. An undergraduate degree (or higher) in a biological or related discipline
2. Strong attention to detail and ability to perform complex laboratory techniques with accuracy
3. Competence in using laboratory software and adhering to laboratory procedures and regulatory standards
4. Ability to build trusted working relationships with peers and senior researchers
5. A team-focused approach, combined with the ability to work independently
Ideally, you will also have:
6. Experience contributing to scientific research projects and discussing results with researchers
7. Previous experience using similar laboratory or molecular pathology techniques
8. Enthusiasm and motivation to contribute scientifically to the group’s research objectives
Department/Directorate Information
The ICR's Division of Cancer Biology is comprehensively characterising the molecular features of cancer, and through strong links with other colleagues elsewhere in The Institute of Cancer Research, London, and at The Royal Marsden NHS Foundation Trust, aims to establish new molecular diagnostics and novel molecular therapeutic targets in cancer. The Sarcoma Molecular Pathology Group is primarily focused on high-risk rhabdomyosarcomas and desmoplastic small round cell tumours that and includes understanding aspects of genetic and epigenetic regulation of differentiation/cell transitioning and the DNA damage response that may be targeted and incorporated into the treatment of these and other sarcomas.
What we offer
9. A dynamic and supportive research environment
10. Access to state-of-the-art facilities and professional development opportunities
11. Collaboration with leading researchers in the field
12. Competitive salary and pension